Holen Sie sich die Stockscreener-App
14.60
1.11%
0.16
Handel nachbörslich:
14.60
Schlusskurs vom Vortag:
$14.44
Offen:
$14.48
24-Stunden-Volumen:
454.02K
Relative Volume:
0.95
Marktkapitalisierung:
$785.07M
Einnahmen:
$217.25M
Nettoeinkommen (Verlust:
$-50.92M
KGV:
-10.28
EPS:
-1.42
Netto-Cashflow:
$-100.85M
1W Leistung:
+4.21%
1M Leistung:
-11.78%
6M Leistung:
-32.38%
1J Leistung:
-55.39%
1-Tages-Spanne:
$14.03
$15.32
1-Wochen-Bereich:
$13.22
$15.32
52-Wochen-Spanne:
$13.22
$41.55
Prothena Corporation Plc Stock (PRTA) Company Profile
Firmenname
Prothena Corporation Plc
Sektor
Branche
Telefon
011-353-1-236-2500
Adresse
77 SIR JOHN ROGERSON'S QUAY, BLOCK C, DUBLIN 2
Vergleichen Sie PRTA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| PRTA | 14.60 | 785.07M | 217.25M | -50.92M | -100.85M | -1.42 |
| VRTX | 450.97 | 116.14B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 738.00 | 81.10B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 605.92 | 36.23B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 244.89 | 31.59B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 113.13 | 27.12B | 3.30B | -501.07M | 1.03B | 11.54 |
Prothena Corporation Plc Stock (PRTA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-01-30 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-12 | Eingeleitet | Deutsche Bank | Buy |
| 2023-04-24 | Eingeleitet | SVB Securities | Outperform |
| 2023-01-27 | Eingeleitet | Piper Sandler | Overweight |
| 2022-11-04 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-28 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-11-19 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-06-18 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2021-06-08 | Bestätigt | Oppenheimer | Outperform |
| 2021-05-26 | Eingeleitet | Citigroup | Buy |
| 2021-02-26 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-02-12 | Hochstufung | Jefferies | Hold → Buy |
| 2021-02-02 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-12-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-07-09 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2019-11-19 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-05-21 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2018-04-23 | Herabstufung | Jefferies | Buy → Hold |
| 2018-04-05 | Bestätigt | Barclays | Overweight |
| 2017-11-20 | Herabstufung | Wedbush | Outperform → Neutral |
| 2017-09-29 | Bestätigt | BTIG Research | Buy |
| 2017-09-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2017-08-17 | Eingeleitet | Evercore ISI | Outperform |
| 2017-07-11 | Eingeleitet | Jefferies | Buy |
| 2017-04-12 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-04-12 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-03-02 | Eingeleitet | Instinet | Buy |
| 2016-12-21 | Eingeleitet | SunTrust | Buy |
| 2016-11-03 | Eingeleitet | Deutsche Bank | Buy |
| 2016-08-04 | Bestätigt | Barclays | Overweight |
| 2016-05-13 | Eingeleitet | Barclays | Overweight |
| 2016-02-19 | Bestätigt | Wedbush | Outperform |
| 2016-01-21 | Eingeleitet | Credit Suisse | Outperform |
Alle ansehen
Prothena Corporation Plc Aktie (PRTA) Neueste Nachrichten
Prothena (NASDAQ:PRTA) Rating Lowered to “Sell” at StockNews.com - Defense World
Prothena FY2024 EPS Forecast Raised by Cantor Fitzgerald - Defense World
Prothena FY2024 EPS Forecast Boosted by Cantor Fitzgerald - MarketBeat
FY2024 EPS Estimates for Prothena Reduced by HC Wainwright - MarketBeat
Prothena (NASDAQ:PRTA) Hits New 12-Month LowHere's What Happened - MarketBeat
Prothena Co. plc (NASDAQ:PRTA) Receives $61.86 Average PT from Brokerages - Defense World
FY2028 EPS Estimates for Prothena Increased by HC Wainwright - MarketBeat
Prothena's SWOT analysis: stock poised for potential breakthroughs amid risks - Investing.com India
Expert Ratings For Prothena Corp - Benzinga
Prothena's (PRTA) Buy Rating Reiterated at HC Wainwright - MarketBeat
Prothena (NASDAQ:PRTA) Announces Quarterly Earnings Results, Beats Estimates By $0.08 EPS - MarketBeat
Prothena Q3 Earnings Beat Estimates, Pipeline Progress in Focus - Yahoo Finance
Prothena Reports Third Quarter 2024 Financial Results and Business Highlights - BioSpace
Prothena (PRTA) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Prothena: Q3 Earnings Snapshot - Marketscreener.com
Prothena Corp PLC Reports Q3 2024 EPS Loss of $1.10, Beats Estimate; Revenue Misses at $1.0 Million - GuruFocus.com
Prothena Reports $59M Q3 Loss, Pipeline Updates Signal Key Trial Results in 2024-25 | PRTA Stock News - StockTitan
Prothena Corporation plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Prothena Co. plc (NASDAQ:PRTA) Receives $61.86 Average Target Price from Brokerages - MarketBeat
Creative Planning Invests $350,000 in Prothena Co. plc (NASDAQ:PRTA) - Defense World
Wellington Management Group LLP's Strategic Acquisition in Proth - GuruFocus.com
Prothena (PRTA) Scheduled to Post Earnings on Tuesday - MarketBeat
Prothena to Report Third Quarter 2024 Financial Results on November 12 - The Bakersfield Californian
Long Term Trading Analysis for (PRTA) - Stock Traders Daily
Prothena (NASDAQ:PRTA) Stock Price Up 5.7%Here's Why - MarketBeat
Prothena (PRTA) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Strength Seen in Prothena (PRTA): Can Its 15.0% Jump Turn into More Strength? - Yahoo Finance
Prothena (NASDAQ:PRTA) Shares Gap UpShould You Buy? - MarketBeat
Prothena's SWOT analysis: stock poised for growth amid clinical milestones - Investing.com
Prothena Co. plc (NASDAQ:PRTA) Short Interest Up 28.1% in October - MarketBeat
Prothena (NASDAQ:PRTA) Sets New 12-Month LowHere's What Happened - MarketBeat
When (PRTA) Moves Investors should Listen - Stock Traders Daily
SG Americas Securities LLC Sells 40,485 Shares of Prothena Co. plc (NASDAQ:PRTA) - MarketBeat
Analysts Set Prothena Co. plc (NASDAQ:PRTA) Target Price at $61.86 - Defense World
State Street Corp's Strategic Reduction in Prothena Corp PLC Hol - GuruFocus.com
Prothena: Delays And Data Uncertainty Undermine Case For Investing (Downgrade) (PRTA) - Seeking Alpha
Prothena Co. plc (NASDAQ:PRTA) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Prothena (NASDAQ:PRTA) Stock Price Crosses Below 200 Day Moving AverageHere's What Happened - MarketBeat
Tau Inhibitors Clinical Trial Pipeline Analysis Demonstrates 25+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight - GlobeNewswire Inc.
(PRTA) Long Term Investment Analysis - Stock Traders Daily
Is Prothena Corporation plc (PRTA) worth investing in despite its undervalued state? - US Post News
Holdings of Prothena Corporation plc (PRTA) are aligned with the stars - SETE News
Daily Progress: Prothena Corporation plc (PRTA) Gain 0.36, Closing at 16.86 - The Dwinnex
Dimensional Fund Advisors LP Reduces Holdings in Prothena Co. plc (NASDAQ:PRTA) - Defense World
Duncan Williams Asset Management LLC Makes New Investment in Prothena Co. plc (NASDAQ:PRTA) - MarketBeat
Algert Global LLC Acquires 28,841 Shares of Prothena Co. plc (NASDAQ:PRTA) - Defense World
Nothing is Better Than Prothena Corporation plc (PRTA) stock at the moment - SETE News
(PRTA) On The My Stocks Page - Stock Traders Daily
Prothena Corporation plc (NASDAQ:PRTA) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough - Simply Wall St
PRTA’s price-to-sales ratio: A comparative analysis with its peers - US Post News
Prothena Corporation plc (PRTA) Stock: A Year of Market Movement, Down and Up - The InvestChronicle
Finanzdaten der Prothena Corporation Plc-Aktie (PRTA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Prothena Corporation Plc-Aktie (PRTA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Walker Karin L | Chief Accounting Officer |
Jan 24 '24 |
Sale |
34.00 |
5,000 |
170,000 |
0 |
| Walker Karin L | Chief Accounting Officer |
Dec 20 '23 |
Option Exercise |
13.53 |
5,000 |
67,650 |
5,000 |
| Walker Karin L | Chief Accounting Officer |
Dec 20 '23 |
Sale |
37.19 |
5,000 |
185,952 |
0 |
| Walker Karin L | Chief Accounting Officer |
Nov 30 '23 |
Option Exercise |
13.53 |
5,000 |
67,650 |
5,000 |
| Walker Karin L | Chief Accounting Officer |
Nov 30 '23 |
Sale |
34.00 |
5,000 |
170,000 |
0 |
1.89%
2.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):